ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.

NDRA · Nasdaq

ENDRA Life Sciences Inc. (NDRA) is a Medical diagnostics research company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for ENDRA Life Sciences Inc. in 2026. The next earnings report is expected on November 16, 2026.

Earnings calendar

Next earnings date

16 Nov 2026

In 89 days

EPS estimate

-0.84

Revenue estimate

0

Past earnings

14 Aug 2026
EPS actual
-0.84 (0.0%)
estimate -0.84
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
18 May 2026
EPS actual
-1.09 (+11.4%)
estimate -1.23
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
31 Mar 2026
EPS actual
-3.26 (-165.0%)
estimate -1.23
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
30 Mar 2026
EPS actual
—
estimate -1.23
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
17 Nov 2025
EPS actual
-2.10 (-7.7%)
estimate -1.95
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

ENDRA Life Sciences Inc. met consensus estimates in its latest earnings report, with EPS of $-0.84 matching estimates and revenue of $0 matching estimates. In the prior quarter, EPS came in ahead of expectations while revenue also met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Sector
Healthcare
Industry
Medical diagnostics research
Country
United States
Exchange
Nasdaq
CEO
Alexander Y. Tokman
Employees
21
IPO date
30 Jun 2017
ISIN
US29273B5003
Website
endrainc.com

Frequently asked questions

When does ENDRA Life Sciences Inc. (NDRA) next report earnings?

ENDRA Life Sciences Inc. (NDRA) is scheduled to report earnings on November 16, 2026.

What was ENDRA Life Sciences Inc.'s most recent earnings date?

ENDRA Life Sciences Inc. (NDRA) last reported earnings on August 14, 2026.

Where is ENDRA Life Sciences Inc. stock listed?

ENDRA Life Sciences Inc. (NDRA) is listed on Nasdaq.